Early intervention, if not preventive administration of functional collagen peptides such as BCP in predisposed or potentially affected individuals (chondrodystrophy, trauma, increased stress from sport, overweight and obesity etc.)is therefore recommended to maintain joint health and functionality for as long as possible, as also suggested by Kwatra (2020) [73]. The gene discussed is OPN1SW; the disease is obesity due to melanocortin 4 receptor deficiency.